4//SEC Filing
Abraxis BioScience, Inc. 4
Accession 0001181431-10-051410
CIK 0001409012operating
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 5:34 PM ET
Size
5.7 KB
Accession
0001181431-10-051410
Insider Transaction Report
Form 4
Transactions
- Disposition to Issuer
Common Stock
2010-10-15−5,758,758→ 0 total
Footnotes (1)
- [F1]Disposed of pursuant to the Agreement and Plan of Merger, dated as of June 30, 2010, among Celgene Corporation ("Celgene"), Artistry Acquisition Corp. ("Merger Sub") and Abraxis BioScience, Inc. ("Abraxis"), whereby Merger Sub merged into Abraxis, with Abraxis continuing as the surviving company and a wholly owned subsidiary of Celgene (the "Merger"), in exchange for (i) an amount in cash equal to $58.00, (ii) 0.2617 of a share of Celgene common stock and (iii) a contingent value right issued by Celgene.
Documents
Issuer
Abraxis BioScience, Inc.
CIK 0001409012
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001409012
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 5:34 PM ET
- Size
- 5.7 KB